Form 57.505 Dialysis Patient Influenza Vaccination

The National Healthcare Safety Network (NHSN)

57.505_Dialysis Patient Flu Vac_BLANK.DOCX

57.505 Dialysis Patient Influenza Vaccination

OMB: 0920-0666

Document [docx]
Download: docx | pdf

Form Approved

OMB No. 0920-xxx

Exp. Date:xx/xx/20xx

www.cdc.gov/nhsn


Page 1 of 1

Dialysis Patient Influenza Vaccination

* required for saving

^ conditionally required




*Facility ID:



*Event #:

*Patient ID:

Social Security #:

Secondary ID:

Medicare #:

Patient Name, Last: First: Middle:

*Gender: M F Other

*Date of Birth:

Ethnicity (Specify):

Race (Specify):

*Event Type: FLUVAX

*Influenza subtype:

Seasonal

Non-Seasonal

*Flu Season:

*Patient Dialysis Modality:

In-center hemodialysis

Home hemodialysis

Peritoneal dialysis

*Patient vaccinated in this facility:

Yes No

*Patient previously vaccinated elsewhere for this flu season:

Yes No

*Patient declined vaccine:

Yes No

Reason(s) vaccine declined (complete either section A or B, but not both)

^A. Medical contraindication(s) (check all that apply)

^B. Personal reason(s) for declining (check all that apply):

Allergy to vaccine components

Fear of needles/injections

History of Guillain-Barré syndrome within 6 weeks of previous influenza vaccination

Fear of side effects

Perceived ineffectiveness of vaccine

Current febrile illness (Temp > 101.5°F)

Religious or philosophical objections

Other (specify): ___________________________

Concern for transmitting vaccine virus to contacts


Other (specify): _________________________

Facility Vaccination Administration Information:

^Date Vaccine Administered: ____/____/_________

^Type of influenza vaccine administered:


Seasonal:

Afluria®

Fluarix®

FluLaval®



Fluvirin®

Fluzone®

Fluzone High-Dose®

Other (specify): ______________

Non-seasonal:

Other (specify): ___________________________

Inactivated influenza vaccine (TIV)

Live-attenuated influenza vaccine (LAIV)

Manufacturer: ____________________________

Lot number: ____________________________

^Route of administration:

Intramuscular

Intranasal

Subcutaneous

Vaccine Information Statement (VIS) Provided to Patient: Yes No Unknown

Edition Date:

Person Administering Vaccine

Vaccinator ID:

Title:

Name: Last:

First:

Middle:

Custom Fields

Label

Label

_______________________

____/____/_________

_______________________

____/____/_________

_______________________

____/____/_________

_______________________

____/____/_________

_______________________

____/____/_________

_______________________

____/____/_________

_______________________

____/____/_________

_______________________

____/____/_________

Comments






Assurance of Confidentiality: The voluntarily provided information obtained in this surveillance system that would permit identification of any individual or institution is collected with a guarantee that it will be held in strict confidence, will be used only for the purposes stated, and will not otherwise be disclosed or released without the consent of the individual, or the institution in accordance with Sections 304, 306 and 308(d) of the Public Health Service Act (42 USC 242b, 242k, and 242m(d)).


Public reporting burden of this collection of information is estimated to average 10 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC, Reports Clearance Officer, 1600 Clifton Rd., MS D-74, Atlanta, GA 30333, ATTN: PRA (0920-0666).

CDC 57.505 rev 1, v 8.1



File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorAmy Schneider
File Modified0000-00-00
File Created2021-01-28

© 2024 OMB.report | Privacy Policy